Cytokine mRNA profile of myelin basic protein reactive T-cell clones in patients with multiple sclerosis

Autoimmunity

Volumn 28, Issue 2, 1998, Pages 77-89

  Vandevyver, Caroline ^a   Motmans, Kris ^a   Stinissen, Piet ^a   Zhang, Jingwu ^a,b   Raus, Jef ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine; MBP specific T cell clones; Multiple sclerosis

Indexed keywords

CYTOKINE; HLA DR2 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0031771184     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939809003870     Document Type: Article

References (37)

1. McFarlin, D.E. and McFurland, H.H., Multiple Sclerosis. N. Engl. J. Med. 1992; 30: 1183-1188.
2. Stinissen, P., Raus, J. and Zhang, J., Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit. Rev Immunol. 1997; 17: 33-75.
3. Spielman, R.S. and Nathanson, N., The genetics of susceptibility to Multiple Sclerosis. Epidemiol. Rev. 1982; 4: 45-65.
4. Zhang, J.W., Markovic, S., Lacet, B., Raus, J., Weiner, H.L. and Hafler, D.A., Increased frequency of IL-2 responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 1994; 179: 973-984.
5. Oksenberg, J., Panzara, M.A., Begovich, B., Mitchell, D., Erlich, H.A., Murray, R.S. et al. Selection for T-cell receptor Vß-Dß-Jß gene rearrangements with specificity for a myelin basic protein peptide in the brain lesions of multiple sclerosis. Nature 1993; 162: 68-70.
6. Kotzin, B.L., Karuturi, S., Chou, Y.K. et al. Preferential T cell receptor beta chain variable gene use in MBP-reactive T cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 1991; 88: 9161-9165.
7. Maimone, D., Gregory, S., Arnason, B.G.W. and Reder, A.T. Cytokine levels in the cerebrospinal fluid and sera of patients with multiple sclerosis. J. Neuroimmunol. 1991; 32: 67-74.
8. Sharief, M.K. and Thompson, E.J. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1993; 56: 156-174.
9. Rieckmann, P., Albrecht, M., Ehrenreich, H., Weber, T. and Michel, U. Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. J. Exp. Med. 1995; 195: 17-29.
10. Olsson, T., Wang, W-Z., Höjeberg, B., Kostulas, V., Jiang, Y.-P., Andersson, G. et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J. Clin. Invest. 1990; 86: 981-985.
11. Link, J., Söderström, M., Ljungdalh, A., Hojeberg, B., Olsson, T., Xu, Z. et al. Organ-specific autoantigens induce interferon-γ. and interleukin-4 mRNA expression in mono-nuclear cells in multiple sclerosis and myasthenia gravis. Neurology 1994; 44: 728-734.
12. Link, J. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta. Neurol. Scand. Suppl. 1994; 158: 1-58.
13. Panitch, H.S., Hirsch, R.L., Schindler, J. and Johnson, K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987; 37: 1097-1102.
14. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A. et al. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol 1995; 37: 82-88.
15. Mokhtarian, P., Shi, Y., Shirazian, D., Morgante, L., Miller, A. and Grob, D. Defective production of anti-inflammatory cytokine. TGF-beta by T-cell lines of putients with active multiple sclerosis. J. Immunol. 1994; 152: 6003-6010.
16. Hofman, K.M., Hinton, D.R., Johnson, K. and Merrill, J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 1989; 170: 607-612.
17. Selmaj, K. and Raine, C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 1988; 23: 339-346.
18. Alvord, E.C., Kies, M.W. Jr. and Suckling, A.J. (Eds) (1984) Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. Alan R. Liss, New York.
19. Ben-Nun, A. and Cohen, I.R. Experimental autoimmune encephalomyelitis (EAE) mediated by T-cell lines: process of selection of lines and characterization of the cells. J. Immunol. 1982; 129: 303-309.
20. Mosmann, T.R. and Coffman, R.L. Two types of mouse helper T-cell clones. Immunology Today 1987; 8: 223-227.
21. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M. et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T-cell clones correlates with encephalitogemcity. Int. Immunol. 1990; 2: 539-544.
22. Racke, M.K., Burnett, D., Pak, S.H., Albert, P.S., Cannella, B., Raine, C.S. et al. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 1995; 154: 450-458.
23. Van der Veen, R.C., Kapp, J.A. and Trotter, J.L. Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells. J. Neuroimmunol. 1993; 48: 221-226.
24. Poser, C.M., Paly, D.W., Scheinberg, L., Mc Donald, I., Davis, F., Ebers, G. et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983; 13: 227-231.
25. Zhang, J.W., Medaer, R., Chin, Y., van den Bergh-Loonen, E., Raus, J. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 1992; 32: 330-338.
26. Zhang, J.W., Medaer, R., Stinissen, P., Hafler, D. and Raus, J. MHC-restricted depletion of human myelin basic protein-reactive T-cells by T-cell vaccination. Science 1993; 216: 1451-1454.
27. Vandevyver, C., Mertens, N., van den Elsen, P., Medaer, R., Raus, J. and Zhang, J. Clonal expansion of myelin basic protein-reactive T-cells in patients with multiple sclerosis: restricted T-cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 1995; 25: 958-968.
28. Legoux, P., Minty, C., Delpech, B., Minty, A.J. and Shire, D. Simultaneous quantification of cytokine mRNAs in interleukin-1ß stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with an internal multi-specific control. Eur. Cytokine Netw. 1992; 3: 553-563.
29. Vandevyver, C., Motmans, K. and Raus, J. Quantification of cytokine mRNA expression by RT-PCR and electrochemiluminescence. Genome Research 1995; 5: 195-201.
30. Zipp, K., Weber, S., Huber, S., Sotgiu, S., Cslonkowska, A., Holler, E. et al. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T-cells, Ann. Neurol. 1995; 38: 723-730.
31. Söderström, M., Hillert, J., Link, J., Navikas, V., Fredrikson, S. and Link, H. Expression of IFN-γ. IL-4 and TGF-8 in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease. Multiple Sclerosis 1995; 1: 173-180.
32. Hermans, G., Stinissen, P., Hauben, L., van den Bergh-Loonen, L., Raus, J. and Zhang, J. The cytokine profile of human myelin basic protein-reactive T cells in multiple sclerosis patients and healthy individuals. Ann. Neurol. 1997; 42: 18-27.
33. Hemmer, B., Vcrgelli, M., Calabresi, P., Huang, T., McFarland, H.F. and Martin, R. Cytokine phenotype of human autoreactivc T cell clones specific for the immuno-dominant myelin basic protein peptide (83-99). J. Neurosc. Res. 1996; 45: 852-862.
34. Brod, S.A., Benjamin, D. and Hafler, D. Restricted T-cell expression of IL-2/IFN-γ mRNA in human inflammatory disease. J. Immunol. 1991; 147: 810-815.
35. Del Prete, G., DeCarli, M., Almerigogna, F., Giudizi, M.G., Biagiotti, R. and Romagnani, S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T-cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993; 150: 353-360.
36. Benvenuto, R., Paroli, M., Buttinelli, C., Franco, A., Barnaba, V., Fieschi, C. and Balsano, F. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin. Exp. Immunol. 1991; 84: 97-102.
37. Olsson, T. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 1992; 40: 211-218.